Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $50,858 | 23 | 60.1% |
| Travel and Lodging | $15,933 | 51 | 18.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,750 | 6 | 11.5% |
| Food and Beverage | $4,417 | 67 | 5.2% |
| Honoraria | $3,570 | 2 | 4.2% |
| Education | $32.27 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $30,085 | 25 | $0 (2024) |
| PFIZER INC. | $27,550 | 30 | $0 (2024) |
| GlaxoSmithKline, LLC. | $16,005 | 15 | $0 (2020) |
| Merck Sharp & Dohme LLC | $3,749 | 32 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $3,215 | 15 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $2,708 | 25 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $1,033 | 1 | $0 (2020) |
| Lilly USA, LLC | $93.60 | 5 | $0 (2021) |
| ViiV Healthcare Company | $90.00 | 1 | $0 (2017) |
| Novo Nordisk Inc | $32.27 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,165 | 23 | PFIZER INC. ($4,981) |
| 2023 | $30,375 | 41 | E.R. Squibb & Sons, L.L.C. ($20,499) |
| 2022 | $20,022 | 26 | PFIZER INC. ($15,102) |
| 2021 | $3,967 | 6 | E.R. Squibb & Sons, L.L.C. ($3,766) |
| 2020 | $17,319 | 19 | GlaxoSmithKline, LLC. ($14,356) |
| 2019 | $1,779 | 7 | GlaxoSmithKline, LLC. ($1,650) |
| 2018 | $207.53 | 3 | PFIZER INC. ($112.65) |
| 2017 | $2,726 | 25 | Novartis Pharmaceuticals Corporation ($2,600) |
All Payment Transactions
150 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | PFIZER INC. | PAXLOVID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/26/2024 | PFIZER INC. | PAXLOVID (Drug) | Travel and Lodging | In-kind items and services | $1,067.16 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/26/2024 | PFIZER INC. | PAXLOVID (Drug) | Travel and Lodging | In-kind items and services | $804.73 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/26/2024 | PFIZER INC. | PAXLOVID (Drug) | Travel and Lodging | In-kind items and services | $412.64 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,520.00 | General |
| 09/17/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $99.98 | General |
| 05/09/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | Cash or cash equivalent | $23.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Travel and Lodging | In-kind items and services | $236.17 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $64.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $59.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $54.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | Cash or cash equivalent | $50.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Travel and Lodging | In-kind items and services | $403.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Travel and Lodging | In-kind items and services | $236.17 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $149.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Travel and Lodging | In-kind items and services | $118.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Travel and Lodging | In-kind items and services | $58.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | Cash or cash equivalent | $34.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Travel and Lodging | Cash or cash equivalent | $23.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/10/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $96.67 | General |
| 01/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $23.75 | General |
| 01/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $14.58 | General |
| 01/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $9.17 | General |
| 12/15/2023 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $51.35 | General |
| 12/08/2023 | PFIZER INC. | PAXLOVID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,900.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 224 | 597 | $41,895 | $22,831 |
| 2022 | 12 | 286 | 621 | $51,439 | $28,413 |
| 2021 | 16 | 506 | 807 | $62,929 | $35,920 |
| 2020 | 12 | 374 | 701 | $63,893 | $29,335 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 127 | $17,780 | $10,109 | 56.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 85 | $8,075 | $4,693 | 58.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 30 | 62 | $4,030 | $2,143 | 53.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 18 | 18 | $3,150 | $2,111 | 67.0% |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | Office | 2023 | 27 | 137 | $2,740 | $1,611 | 58.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 20 | 20 | $3,000 | $1,179 | 39.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 32 | 72 | $1,080 | $604.80 | 56.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 15 | 15 | $1,125 | $245.25 | 21.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 20 | 61 | $915.00 | $134.20 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 186 | $25,400 | $15,052 | 59.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 86 | $8,050 | $5,160 | 64.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 22 | 22 | $3,850 | $2,643 | 68.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 24 | 45 | $2,925 | $1,839 | 62.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 24 | 24 | $3,600 | $876.00 | 24.3% |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | Office | 2022 | 13 | 66 | $1,320 | $778.92 | 59.0% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 22 | 22 | $1,140 | $767.14 | 67.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 20 | 20 | $1,500 | $335.94 | 22.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 20 | 20 | $1,500 | $329.90 | 22.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $384.00 | $315.96 | 82.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 35 | 73 | $1,095 | $215.97 | 19.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 25 | 45 | $675.00 | $99.99 | 14.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 44 | 202 | $26,270 | $16,345 | 62.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 79 | $7,110 | $4,562 | 64.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 31 | 67 | $4,355 | $2,703 | 62.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 20 | 20 | $3,500 | $2,447 | 69.9% |
About Andrea Phillips, M.C
Andrea Phillips, M.C is a Family Medicine healthcare provider based in Jackson, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558462382.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Andrea Phillips, M.C has received a total of $84,561 in payments from pharmaceutical and medical device companies, with $8,165 received in 2024. These payments were reported across 150 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($50,858).
As a Medicare-enrolled provider, Phillips has provided services to 1,390 Medicare beneficiaries, totaling 2,726 services with total Medicare billing of $116,499. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Jackson, MS
- Active Since 09/26/2006
- Last Updated 07/09/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558462382
Products in Payments
- ELIQUIS (Drug) $18,265
- PAXLOVID (Drug) $11,785
- VERQUVO (Drug) $3,549
- ENTRESTO (Drug) $1,589
- Non-Covered $1,033
- EMGALITY (Drug) $74.09
- ZEPATIER (Drug) $35.66
- Ozempic (Drug) $32.27
- TRULICITY (Drug) $19.51
- LEQVIO (Drug) $12.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Jackson
Dr. Matt Rosenberg, M.d, M.D
Family Medicine — Payments: $677,942
Dr. Krishan Gupta, M.d, M.D
Family Medicine — Payments: $26,295
Charles Pewitt, Do, DO
Family Medicine — Payments: $25,061
Alexander Osowa, Md, MD
Family Medicine — Payments: $22,911
Dr. Channing Smith, M.d, M.D
Family Medicine — Payments: $22,627
Dr. Stephen Arntz, M.d, M.D
Family Medicine — Payments: $21,354